Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase II (BRF113710) single-arm, open-label study of GSK2118436 in BRAF mutant metastatic melanoma
dabrafenib
BRF113710
NCT01153763
Melanoma
Phase 2
 
This study is still ongoing, however data related to the publication(s) is available.
September 2013

Powered by ideaPoint, Inc.